Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Esophageal Neoplasms × Amyloid × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Tobacco Use Disorder 1 Smoking Cessation 1 Neoplasms 1 Esophageal Neoplasms 1 Digestive System Abnormalities 1 Acquired Immunodeficiency Syndrome 1

Interventions

Paclitaxel 15 pembrolizumab 14 Radiotherapy 11 Cisplatin 11 Esophagectomy 9 Drug Therapy 9 Carboplatin 9 Radiation 8 Nivolumab 7 Immunotherapy 7 Fluorouracil 7 Blood Specimen Collection 7 Chemoradiotherapy 6 Capecitabine 6 Surgical Procedures, Operative 5 Oxaliplatin 5 Immune Checkpoint Inhibitors 5 nimotuzumab 4 Trastuzumab 4 130-nm albumin-bound paclitaxel 4 trastuzumab deruxtecan 3 tislelizumab 3 patritumab deruxtecan 3 camrelizumab 3 Surveys and Questionnaires 3 Specimen Handling 3 Ramucirumab 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Endoscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02530983 2025-04-11

UDD

Mayo Clinic

Gastrointestinal

Digestive System Abnormalities, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡